Grupo de Obesidad Balon Gastrico
CONTACT US

Health Alert Ultra Lipo No. 042-2024

Directorate of Medicines and Biological Products

ULTRA LIPO

Product Name: ULTRA LIPO
Source of Alert: Complaint
Internal Identification No.: MA2402-020
Alert No.: 042-2024
Bogotá, February 28, 2024

The National Institute for Food and Drug Monitoring (Invima) warns the public about the illegal sale of the product "ULTRA LIPO," which is allegedly marketed as a fat burner and weight loss method.

pastillas para adelgazar

This product does not have an approved health registration by Invima, making its sale in Colombia illegal.

Health Risks of This Alleged Weight Loss Method

Using ULTRA LIPO without medical supervision and without health registration can cause serious health issues. Associated risks include:

  • Digestive and stomach problems such as diarrhea, vomiting, stomach pain, and constipation.
  • Elevated blood pressure, palpitations, heart disease, anxiety, and tremors.
  • Insomnia, nightmares, and fatigue.
  • Damage to organs such as the heart, kidneys, and liver.

Invima has previously issued health alerts about this product, highlighting the dangers of consuming unregulated and counterfeit products.

For more information, please refer to health alerts No. 178-2021 and 349-2023.

Recommendations for the Public Regarding This Alleged Weight Loss Method

Avoid purchasing ULTRA LIPO.

Do not buy medications or dietary supplements without a valid health registration.

If you are using this product:

Recommendations for Health Authorities Regarding This Alleged Weight Loss Method

Conduct inspections at establishments where ULTRA LIPO might be sold.

Take measures to manage its destruction if the product is found.

Report any findings of this product in establishments or online channels to Invima.

Share this alert with other health entities and sector stakeholders.

Measures for the National Pharmacovigilance Network

Pharmacovigilance programs should actively seek adverse reactions associated with this product and notify Invima.

For further details on this alert, you can access the original document on Invima’s website.

For more information about Gastric Balloon treatment, please visit our Gastric Balloon page.

Other Articles